International
Available Domestic
Available Domestic
Dragon Pharma
Dragon Pharma Glow Blend 60 mg - Three Repair Peptides Vial
Injection · 60 mg · vial
Out of stock
Dragon Pharma Glow Blend 60 mg is a three-component repair blend of BPC-157, TB-500 and GHK-Cu in one lyophilised vial. It brings the two repair-pathway peptides together with the copper peptide studied for collagen and skin, all from a single reconstitution.
Each vial is GMP-manufactured and HPLC-verified, with a Certificate of Analysis on file. Reconstitute with bacteriostatic water. Glow Blend 60 mg for sale with U.S. and international shipping.
Discreet plain packaging
Worldwide reship guarantee
Crypto & card accepted
Product overview
Dragon Pharma Glow Blend 60 mg - BPC-157, TB-500 and GHK-Cu
Dragon Pharma Glow Blend 60 mg combines three repair peptides in one vial: BPC-157, TB-500 and GHK-Cu. BPC-157 and TB-500 cover the tendon, gut and cell-migration routes, while GHK-Cu is a copper-binding tripeptide studied for collagen synthesis and skin remodelling. No component has a licensed product or a human dose. Glow Blend for sale from a GMP manufacturer with batch testing and a Certificate of Analysis on file.
- BPC-157, TB-500 and GHK-Cu in one 60 mg lyophilised vial
- Typical market proportion 5:1:1, exact weights on the label
- Only BPC-157 has a measured half-life, from rat studies
- GMP-manufactured, HPLC-verified, COA on file per batch
How the Three-Peptide Blend Works
BPC-157 is described in models of angiogenesis and mucosal repair, TB-500 is the thymosin beta-4 fragment that regulates actin and cell migration, and GHK-Cu is studied for collagen synthesis, where it stimulates metalloproteinases and their inhibitors at once. Combining them means the vial holds one fixed ratio, and that ratio is what is drawn. The copper peptide is also listed on its own as GHK-Cu and GHK-Cu 50 mg, while BPC 157 and TB 500 come as separate vials.
Research Amounts and Handling
No human dose exists for any component, so every figure is research practice. Reported work uses 150 to 375 mcg of BPC-157 twice daily, 1 to 2 mg of GHK-Cu per day in preclinical models, and a TB-500 loading phase of about 2.5 mg twice weekly for four to six weeks followed by 2.5 mg per week. In a fixed-ratio blend those amounts move together. Reconstitute with bacteriostatic water: 3 ml gives 20 mg per ml, so 1 mg measures 0.05 ml, . Keep the powder at 2-8 C away from light.
Quality & Authenticity
Every batch is produced under GMP conditions and checked by independent HPLC, with the Certificate of Analysis held for the batch, which matters most in a blend, where three components must be present at the stated amounts. The typical market proportion is 5:1:1 of GHK-Cu, BPC-157 and TB-500, so GHK-Cu carries most of the mass; the exact weights on this vial are stated only on its label. Pain and redness at the injection site, dizziness and nausea are reported, and reactions to the copper in GHK-Cu are a specific consideration.
For laboratory research only. Consult a healthcare professional before use.
Specifications
| Trade Name | Glow Blend 60 mg |
| Generic Name | BPC-157, TB-500 and GHK-Cu blend |
| Manufacturer | Dragon Pharma |
| Dosage | 60 mg of peptide per lyophilised vial |
| Package | 1 vial of powder for reconstitution |
| Drug Class | Research peptide blend (three repair peptides) |
| Administration | Reconstitute with bacteriostatic water, subcutaneous injection |
| Reference Half-Life | BPC-157 7.9 to 30 minutes in rats; others not established |
| Shipping | International and U.S. domestic options |
Stacks
Consult a healthcare professional before any cycle. Doses are common community protocols.
FAQ
Before you ask
Questions, answered
It is a three-component repair blend of BPC-157, TB-500 and GHK-Cu in one lyophilised vial holding 60 mg of peptide. BPC-157 and TB-500 cover the tendon, gut and cell-migration routes, and GHK-Cu is the copper tripeptide studied for collagen and skin. No component has a licensed product or a human dose.
Each peptide takes a different route: BPC-157 is studied in models of angiogenesis and mucosal repair, TB-500 regulates actin and cell migration as a thymosin beta-4 fragment, and GHK-Cu is studied for collagen synthesis. Blending them puts all three routes in one solution, but it also fixes the ratio, so the amount of one component cannot be changed without changing the others.
The blend gives all three peptides from one reconstitution and one draw, which suits a protocol that wants the same ratio every time. Separate BPC 157, TB 500 and GHK-Cu vials let each peptide be adjusted on its own, and they let a single peptide be run without the other two. Neither route has human data behind it.
No human dose exists. Reported work uses 150 to 375 mcg of BPC-157 twice daily, 1 to 2 mg of GHK-Cu per day in preclinical models, and a TB-500 loading phase of about 2.5 mg twice weekly for four to six weeks. In a fixed-ratio blend these move together. Reconstituting with 3 ml of bacteriostatic water gives 20 mg per ml, so 1 mg measures 0.05 ml.
Pain and redness at the injection site are the usual local reports, with dizziness and nausea described for BPC-157. GHK-Cu contains copper, so reactions to copper are a specific consideration, and the peptide stimulates metalloproteinases and their inhibitors at the same time, which is an unresolved balance in the literature. No long-term human safety data exist for the combination.
Yes. The 60 mg vial is listed on this page with international and U.S. domestic shipping options, and the price charged matches the option you select. Orders are dispatched after payment confirmation. The product is sold strictly for laboratory research and is not a licensed medicine in any country.
No reviews yet
Be the first to share your experience with Dragon Pharma Glow Blend 60 mg - Three Repair Peptides Vial
Log in to write a reviewComplete the cycle
Stack it with
International
Available Domestic
International
International